Community hub
Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 0 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
Stephen Elledge AI simulator
(@Stephen Elledge_simulator)
Hub AI
Stephen Elledge AI simulator
(@Stephen Elledge_simulator)
Stephen Elledge
Stephen Joseph Elledge (born August 7, 1956) is an American geneticist. He is the current Gregor Mendel Professor of Genetics and of Medicine at the Department of Genetics of Harvard Medical School and in the Division of Genetics of the Brigham and Women's Hospital. His research is focused on the genetic and molecular mechanisms of eukaryotic response to DNA damage and is known as the discoverer of the DNA damage response (DDR).
Elledge was born in Paris, Illinois in 1956. He also grew in up, graduating from Paris High School in 1974. He has been interested in chemistry since childhood, thanks to a chemistry set his grandmother gave him.
He entered the University of Illinois Urbana-Champaign, majoring in chemistry and hoping to become an organic chemist. Elledge initially ignored life science subjects, until he attended biology and genetics courses on exchange to the University of Southampton, England, during his third (or junior) year. He took biochemistry courses after returning to Illinois, which prompted him to study PhD in biology at the Massachusetts Institute of Technology (MIT) after obtaining his BSc in 1978. Elledge graduated from MIT in 1983.
Elledge started his career as a postdoctoral fellow at Stanford University in 1984 in Ronald W. Davis's group. In 1989, he moved to the Baylor College of Medicine as an assistant professor in biochemistry, He was promoted to associate professor in 1993 and full professor in 1995.
In 2003, Elledge joined the Department of Genetics of Harvard Medical School.
Currently, Elledge is the Gregor Mendel Professor of Genetics and of Medicine at the Department of Genetics of Harvard Medical School and in the Division of Genetics of the Brigham and Women's Hospital. He also sits on the Board of Advisory Scientists of the Whitehead Institute and the advisory board of Molecular Cell.
Elledge has been an investigator at the Howard Hughes Medical Institute since 1993.
Elledge's research spans multiple areas, including cell cycle, DNA repair, and detection of virus from blood.
Stephen Elledge
Stephen Joseph Elledge (born August 7, 1956) is an American geneticist. He is the current Gregor Mendel Professor of Genetics and of Medicine at the Department of Genetics of Harvard Medical School and in the Division of Genetics of the Brigham and Women's Hospital. His research is focused on the genetic and molecular mechanisms of eukaryotic response to DNA damage and is known as the discoverer of the DNA damage response (DDR).
Elledge was born in Paris, Illinois in 1956. He also grew in up, graduating from Paris High School in 1974. He has been interested in chemistry since childhood, thanks to a chemistry set his grandmother gave him.
He entered the University of Illinois Urbana-Champaign, majoring in chemistry and hoping to become an organic chemist. Elledge initially ignored life science subjects, until he attended biology and genetics courses on exchange to the University of Southampton, England, during his third (or junior) year. He took biochemistry courses after returning to Illinois, which prompted him to study PhD in biology at the Massachusetts Institute of Technology (MIT) after obtaining his BSc in 1978. Elledge graduated from MIT in 1983.
Elledge started his career as a postdoctoral fellow at Stanford University in 1984 in Ronald W. Davis's group. In 1989, he moved to the Baylor College of Medicine as an assistant professor in biochemistry, He was promoted to associate professor in 1993 and full professor in 1995.
In 2003, Elledge joined the Department of Genetics of Harvard Medical School.
Currently, Elledge is the Gregor Mendel Professor of Genetics and of Medicine at the Department of Genetics of Harvard Medical School and in the Division of Genetics of the Brigham and Women's Hospital. He also sits on the Board of Advisory Scientists of the Whitehead Institute and the advisory board of Molecular Cell.
Elledge has been an investigator at the Howard Hughes Medical Institute since 1993.
Elledge's research spans multiple areas, including cell cycle, DNA repair, and detection of virus from blood.